- Home
- VRSK vs DXCM Comparison
VRSK vs DXCM Comparison
Compare VRSK & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRSK
- DXCM
- Stock Information
- Founded
- VRSK 1971
- DXCM 1999
- Country
- VRSK United States
- DXCM United States
- Employees
- VRSK N/A
- DXCM N/A
- Industry
- VRSK Business Services
- DXCM Medical/Dental Instruments
- Sector
- VRSK Consumer Discretionary
- DXCM Health Care
- Exchange
- VRSK Nasdaq
- DXCM Nasdaq
- Market Cap
- VRSK 40.9B
- DXCM 34.1B
- IPO Year
- VRSK 2009
- DXCM 2005
- Fundamental
- Price
- VRSK $300.51
- DXCM $83.52
- Analyst Decision
- VRSK Hold
- DXCM Strong Buy
- Analyst Count
- VRSK 10
- DXCM 20
- Target Price
- VRSK $302.40
- DXCM $98.50
- AVG Volume (30 Days)
- VRSK 917.8K
- DXCM 3.8M
- Earning Date
- VRSK 07-30-2025
- DXCM 07-30-2025
- Dividend Yield
- VRSK 0.60%
- DXCM N/A
- EPS Growth
- VRSK 27.61
- DXCM N/A
- EPS
- VRSK 6.84
- DXCM 1.33
- Revenue
- VRSK $2,930,700,000.00
- DXCM $4,148,000,000.00
- Revenue This Year
- VRSK $8.93
- DXCM $16.74
- Revenue Next Year
- VRSK $7.23
- DXCM $15.29
- P/E Ratio
- VRSK $43.92
- DXCM $62.58
- Revenue Growth
- VRSK 7.20
- DXCM 9.11
- 52 Week Low
- VRSK $257.59
- DXCM $57.52
- 52 Week High
- VRSK $322.92
- DXCM $117.19
- Technical
- Relative Strength Index (RSI)
- VRSK 41.40
- DXCM 49.26
- Support Level
- VRSK $299.27
- DXCM $82.73
- Resistance Level
- VRSK $308.19
- DXCM $85.92
- Average True Range (ATR)
- VRSK 4.99
- DXCM 2.63
- MACD
- VRSK -0.86
- DXCM -0.09
- Stochastic Oscillator
- VRSK 7.98
- DXCM 54.33
About VRSK Verisk Analytics Inc.
Verisk Analytics is the leading provider of statistical, actuarial, and underwriting data for the United States' property and casualty insurance industry. Verisk leverages a vast contributory database and proprietary data assets to develop analytical tools helping insurance providers to better assess and price risk, achieve operational efficiency and optimize claim settlement processes. While Verisk also offers tools to quantify costs after loss events occur and to detect fraudulent activity, it is expanding into adjacent markets of life insurance, marketing, and non-US operations.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.